DK1100528T3 - Anvendelse af hidtil ukendte midler, der inducerer celledød i samvirke med interferoner - Google Patents

Anvendelse af hidtil ukendte midler, der inducerer celledød i samvirke med interferoner

Info

Publication number
DK1100528T3
DK1100528T3 DK99936659T DK99936659T DK1100528T3 DK 1100528 T3 DK1100528 T3 DK 1100528T3 DK 99936659 T DK99936659 T DK 99936659T DK 99936659 T DK99936659 T DK 99936659T DK 1100528 T3 DK1100528 T3 DK 1100528T3
Authority
DK
Denmark
Prior art keywords
interferons
cell death
association
novel agents
induce cell
Prior art date
Application number
DK99936659T
Other languages
English (en)
Inventor
Marcel Koken
Frederique Quignon
The Hugues De
Jean-Claude Ameisen
Bels Frederic De
Original Assignee
Inst Nat Sante Rech Med
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Centre Nat Rech Scient filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK1100528T3 publication Critical patent/DK1100528T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Coils Or Transformers For Communication (AREA)
  • Inorganic Fibers (AREA)
  • Filters And Equalizers (AREA)
DK99936659T 1998-07-31 1999-07-30 Anvendelse af hidtil ukendte midler, der inducerer celledød i samvirke med interferoner DK1100528T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9809886A FR2781674B1 (fr) 1998-07-31 1998-07-31 Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons
PCT/FR1999/001901 WO2000007616A2 (fr) 1998-07-31 1999-07-30 Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons

Publications (1)

Publication Number Publication Date
DK1100528T3 true DK1100528T3 (da) 2002-11-04

Family

ID=9529292

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99936659T DK1100528T3 (da) 1998-07-31 1999-07-30 Anvendelse af hidtil ukendte midler, der inducerer celledød i samvirke med interferoner

Country Status (11)

Country Link
US (1) US7217413B1 (da)
EP (1) EP1100528B1 (da)
JP (3) JP2002522395A (da)
AT (1) ATE226087T1 (da)
AU (1) AU5168099A (da)
DE (1) DE69903559T2 (da)
DK (1) DK1100528T3 (da)
ES (1) ES2181461T3 (da)
FR (1) FR2781674B1 (da)
PT (1) PT1100528E (da)
WO (1) WO2000007616A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR874601A0 (en) * 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
US8394422B2 (en) 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
JP2006503852A (ja) * 2002-09-25 2006-02-02 ユニバーシティー オブ ロチェスター 抗癌薬としてのカスパーゼインヒビター
CN101863958B (zh) 2002-11-07 2012-07-18 新南创新私人有限公司 对线粒体通透性转换的诱导
JP2010222289A (ja) * 2009-03-23 2010-10-07 Tokyoto Igaku Kenkyu Kiko 細胞死を予防するための医薬剤
WO2011073739A1 (en) 2009-12-15 2011-06-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods, pharmaceutical compositions and kits for use in the treatment of adult t-cell leukemia/lymphoma
EP3570849B1 (en) * 2017-01-18 2024-12-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions for the treatment patients suffering from myeloproliferative disorders
JP7336359B2 (ja) * 2019-03-13 2023-08-31 株式会社明電舎 配電系統制御装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
US20020001841A1 (en) * 1998-06-26 2002-01-03 Keld Kaltoft Continuous t-cell lines
AU8524901A (en) * 2000-08-25 2002-03-13 Aventis Pharma Inc Membrane penetrating peptides and uses thereof

Also Published As

Publication number Publication date
DE69903559T2 (de) 2003-02-27
AU5168099A (en) 2000-02-28
DE69903559D1 (de) 2002-11-21
WO2000007616A2 (fr) 2000-02-17
WO2000007616A3 (fr) 2000-04-20
EP1100528B1 (fr) 2002-10-16
FR2781674B1 (fr) 2002-06-28
ATE226087T1 (de) 2002-11-15
ES2181461T3 (es) 2003-02-16
US7217413B1 (en) 2007-05-15
FR2781674A1 (fr) 2000-02-04
JP2014129404A (ja) 2014-07-10
JP2011190280A (ja) 2011-09-29
PT1100528E (pt) 2002-12-31
EP1100528A2 (fr) 2001-05-23
JP2002522395A (ja) 2002-07-23

Similar Documents

Publication Publication Date Title
IL133883A0 (en) Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
TR200101764T2 (tr) Yeni bileşikler.
EP1053006A4 (en) INHIBITION OF AN ASSOCIATED STIMULATION PATHWAY AND MIXED CHIMERISM IN TRANSPLANTATION
MXPA00010070A (es) Mejora de respuestas inmunes medidas de proteina de fusion anticuerpo-citoquina por co-administracion con inhibidor de angiogenesis.
IL142824A (en) Lipoic acid derivatives and their use as anti metabolic agents
DE69837393D1 (de) Stimulierung von hämatopoietischen zellen im vitro
ES495315A0 (es) Mejoras en electrodos de difusion de gas para pilas electroquimicas.
EA200001245A1 (ru) КОМПОЗИЦИИ НА ОСНОВЕ ПИРРОЛО [2,3d] ПИРИМИДИНОВ И ИХ ПРИМЕНЕНИЕ
FI20070393L (fi) Parannuksia henkilökohtaisissa säteilyn annosmittareissa tai niihin liittyen
WO2002041843A3 (en) Antiinflammation agents
IL132951A0 (en) Compounds preparation and use for transferring nucleic acids into cells
DK539284D0 (da) Organer til formindskelse af skudspredningen i et vaabensystem
BG40955A3 (en) Acaricide means and method for protection from acars
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
DE3483704D1 (de) Phenylchinolinsaeure und derivate als antitumormittel.
DK255283D0 (da) Middel til bekaempelse af skadelige organismer, dets fremstilling og anvendelse samt substituerede aminoketaler til anvendelse i midlet
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
SI1147103T1 (en) Phenantrhridine-n-oxides with pde-iv inhibiting activity
TR199802704T2 (xx) H�V tedavisinde Vx478, Zidov�din, FTC ve/veya 3TC i�eren kombinasyonlar�n kullan�m�.
NZ502800A (en) The use of apoptin in determining the transforming capability of tumorigenic or tumor promoting agents
ATE71149T1 (de) Monoklonale antikoerper.
FI832718A7 (fi) Uusia verenpainetta alentavia aineita koskevia tai näihin liittyviä parannuksia.
SE9704170D0 (sv) Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents